Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03161236 · ClinicalTrials.gov registry record · NA
Assessing Balance Changes Following an Exercise Program Among Middle-Aged Adults
A NA study of Balance Changes, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT03161236: Completed NA study of Balance Changes, sponsored by Loma Linda University.
NCT03161236 is a NA study of Balance Changes that has completed, run by Loma Linda University. The registered enrollment target is 52 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03161236, a NA study of Balance Changes, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
This graduate student research study has two purposes; the first purpose is to examine the criterion validity of the Y Balance Test (YBT) with the Limits of Stability Test (LOS) in healthy middle-aged adults. The second purpose is to examine balance changes using the YBT following a home-based exercise program.
Primary Outcome
The test assesses performance during single-leg balance with a reaching task in the anterior (ANT), posteromedial (PM), and posterolateral (PL) directions to determine lower extremity movement asymmetry and balance deficits. ANT, PM, and PL are a composite measurement.
Conditions Studied
Interventions
- OTHER home exercise program
- OTHER non exercise program
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2016-10-31 |
| Est. Completion | 2019-06-01 |
| Phase | NA |
What the finished NCT03161236 record still lists
NCT03161236 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Balance Changes appearing as the primary indexed condition, and to 2 interventions - of which home exercise program is the first listed.
NCT03161236 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03161236 about?
NCT03161236 is a clinical study titled "Assessing Balance Changes Following an Exercise Program Among Middle-Aged Adults". This graduate student research study has two purposes; the first purpose is to examine the criterion validity of the Y Balance Test (YBT) with the Limits of Stability Test (LOS) in healthy middle-aged adults. The second purpose is to examine balance changes using the YBT following a home-based exerc...
What is the current status of trial NCT03161236?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2016-10-31. Estimated completion is 2019-06-01.
What conditions does trial NCT03161236 study?
This clinical trial studies the following conditions: Balance Changes.
What interventions are being tested in trial NCT03161236?
The interventions under investigation include: home exercise program (OTHER), non exercise program (OTHER).
Who is sponsoring clinical trial NCT03161236?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03161236 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03161236's enrollment target sits among peer trials
52 1272nd of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI